×

Warning

JUser: :_load: Unable to load user with ID: 1123

NeoStem to Present at Multiple September Conferences

|

New York, September 3, 2013 — NeoStem, Inc. (Nasdaq: NBS) (“NeoStem” or the “Company”), a leader in the emerging cellular therapy market, announced today that the Company and its subsidiary, Progenitor Cell Therapy (“PCT”), will present at multiple upcoming conferences in September.

European Society of Cardiology Congress: Acute Cardiac Care 2013

  • Date and Time: Tuesday, September 3, 3:30 PM CEST
  • Venue: Congress Centre, Amsterdam, The Netherlands
  • Session: Infarction acute phase STEMI (Moderated posters)
  • Speaker: Jonathan Sackner-Bernstein, MD, FACC, Vice President, Clinical Development and Regulatory Affairs

Rodman & Renshaw 15th Annual Healthcare Conference

  • Date and Time: Monday, September 9, 10:50 AM EDT
  • Venue: Millennium Broadway Hotel, New York, New York
  • Session: Company presentation
  • Speaker: Robin L. Smith, MD, MBA, Chairman and CEO

International Society for Cellular Therapy (ISCT) North American Regional Meeting 2013

  • Date and Time: Tuesday, September 10, 10:30 AM EDT
  • Venue: Hyatt at Penn’s Landing, Philadelphia, Pennsylvania
  • Session: Commercialization Case Study: Cell Therapy from Concept to Market
  • Speaker: Robert A. Preti, Ph.D., Chief Scientific Officer, NeoStem, and President, Progenitor Cell Therapy (PCT)

Stifel Annual Healthcare Conference 2013

  • Date and Time: Wednesday, September 11, 2:40 PM EDT
  • Venue: Four Seasons Hotel, Boston, Massachusetts
  • Session: Company presentation
  • Speaker: Robin L. Smith, MD, MBA, Chairman and CEO

Heart Failure Society of America 17th Annual Scientific Meeting

  • Date and Time: Monday, September 23, 4:00 PM EDT
  • Venue: The Peabody Orlando Hotel, Orlando, Florida
  • Session: Can Cell Therapy Put Systolic Heart Failure on the Endangered Species List?
  • Speaker: Douglas W. Losordo, MD, FACC, FAHA, Chief Medical Officer

Aegis Capital Corp. 2013 Healthcare Conference

  • Date and Time: Thursday, September 26, 9:00 AM PDT
  • Venue: The Encore at Wynn, Las Vegas, Nevada
  • Session: Company Presentation
  • Speaker: Robin L. Smith, MD, MBA, Chairman and CEO

BioCentury Newsmakers in the Biotech Industry

  • Date and Time: Friday, September 27, 10:00 AM EDT
  • Venue: The Millennium Broadway Hotel & Conference Center, New York, New York
  • Session: Company Presentation
  • Speaker: Robin L. Smith, MD, MBA, Chairman and CEO

The Symposium on Advanced Wound Care

  • Date and Time: Saturday, September 28, 4:10 PM PDT
  • Venue: Bally’s Las Vegas, Las Vegas, Nevada
  • Session: Cell Therapy for Critical Limb Ischemia
  • Speaker: Douglas W. Losordo, MD, FACC, FAHA, Chief Medical Officer

Stem Cells & Regenerative Medicine Congress

  • Date and Time: Monday, September 30, 1:50 PM EDT
  • Venue: The Hyatt Regency, Cambridge, Massachusetts
  • Session: Capital formation strategies for stem cell and regenerative medicine companies
  • Session Chair: Robin L. Smith, MD, MBA, Chairman and CEO

About NeoStem

NeoStem, Inc. is a leader in the emerging cellular therapy industry. Our business model includes the development of novel proprietary cell therapy products as well as operating a contract development and manufacturing organization providing services to others in the regenerative medicine industry. The combination of a therapeutic development business and revenue-generating service provider business provides the Company with capabilities for cost effective in-house product development and immediate revenue and cash flow generation.

- See more at: http://www.equities.com/index.php?option=com_k2&view=item&id=9813&Itemid=246#sthash.a1dx1OAc.dpuf

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Companies

Symbol Name Price Change % Volume
NZRFF Nz Refining Co Ltd 1.86 0.00 0.00 0

Comments

Emerging Growth

AfterMaster Inc

Studio One Media Inc is a diversified media and technology company. It is engaged in the development and commercialization of proprietary, edge audio and video technologies for professional and consumer…

Private Markets

Santo Diablo Mezcal

Santo Diablo Mezcal has been created to capitalize on a boom sector of the beverage market currently full of many small unmemorable products by producing one sexy, household, easily recognizable…

Snapchat

Snapchat is the fastest way to share a moment with friends. The mobile app, allows users to not only share photos with friends but also control how long they can…